GENE THERAPY VECTOR

CLINICAL CENTER GENOTYPING CENTER
Information regarding Cystic Fibrosis, the types of research being performed to finds its cure.  Learn more about gene therapy, and treatments for Cystic Fibrosis as well as volunteering opportunities.
The Center has many research laboratories dedicated to finding a cure for Cystic Fibrosis.  Meet the different lab directors, their lab members and the laboratories particular focus.
A complete list of publications from the Centers lab directors that are related to Cystic Fibrosis.
Apply for open positions at the Cystic Fibrosis Research Development Center.
Visit other websites of organizations and associations affiliated with Cystic Fibrosis.
Letter from the Director addressing the Centers continued plan for the future.
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

 

 

Beth L. Laube

Beth Home | Publications | Lab Members

 

 

Beth L. Laube

Associate Professor
The Johns Hopkins University School of Medicine
Department of Pediatrics
Division of Pediatric Pulmonary
Baltimore, MD
600 North Wolfe Street
Baltimore, Maryland 21287-2533

blaube@jhmi.edu 
 

 

Beth Laube

       
  Publications
 

Laube, B.L., Georgopoulos, A., and Adams, III, G.K.  Proving the efficacy of insulin delivered through the lungs as an aerosol.  J. Biopharm. Sci.  3:163-169, 1992.

 

Laube, B.L., Bowes, S.M., Links, J.M., Thomas, K.K., and Frank, R.  Acute exposure to acid fog: Effects on mucociliary clearance.  Am. Rev. Respir. Dis. 147:1105-1111, 1993.

 
Laube, B.L., Georgopoulos, A., and Adams, G.K., III.  Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients.  JAMA 269:2106-2109, 1993.
 

Laube, B.L., Georgopoulos, A., and Adams, G.K., III.  Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients.  JAMA-Czech/Slovak  1:631-634, 1993.

 

Harrison, K.S., and Laube, B.L.  Bronchodilator pre-treatment improves aerosol deposition uniformity in HIV patients who cough while inhaling aerosolized pentamidine.  Chest 106:421-26, 1994.

 

Bowes, S.M., III, Francis, M., Laube, B.L., and Frank R.  Acute exposure to acid fog: Influence of breathing pattern on effective dose. Am. Indust. Hygiene Assoc. J. 56:143-150, 1995.

 

Laube, B.L., Auci, R.M., Shields, D.E., Christiansen, D.H., Lucas, M.K., Fuchs, H.J., Rosenstein, B.J.  Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.  Am. J. Respir. Critical Care Med. 153:752-760, 1996.

 

Laube B.L.   In vivo measurements of aerosol dose and distribution: clinical relevance.  J. Aerosol. Med. 9:S-77-S-91, 1996.

 

Laube, B.L., Edwards, A. M., Dalby, R.N., Creticos, P. S., Norman, P.S.  The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma. J. Allergy Clin. Immunol. 101:475-83, 1998.

 

Laube, B.L., Jashnani R., Dalby, R.N. Predicting the lung deposition of cromolyn sodium from in vitro estimates.  J. Aerosol Med. 11:S35-S42, 1998.

 

Laube, B.L., Benedict, G.W., Dobs, A.S. Time to peak insulin level, relative bioavailability and effect of site of deposition of nebulized insulin in patients with non-insulin dependent diabetes mellitus.  J. Aerosol Med. 11:153-173, 1998.

 

Publications Next

615 N. Wolfe Street, Baltimore, MD 21205